PepGen Inc. (NASDAQ:PEPG) Short Interest Update

PepGen Inc. (NASDAQ:PEPGGet Free Report) was the recipient of a significant growth in short interest in February. As of February 15th, there was short interest totalling 852,600 shares, a growth of 26.2% from the January 31st total of 675,600 shares. Based on an average daily volume of 2,050,000 shares, the short-interest ratio is currently 0.4 days. Approximately 3.1% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Bank of America lowered PepGen from a “neutral” rating to an “underperform” rating and set a $3.00 target price for the company. in a report on Monday, December 16th. HC Wainwright reiterated a “buy” rating and set a $16.00 target price on shares of PepGen in a research note on Monday, February 24th. Finally, Wedbush decreased their price target on shares of PepGen from $19.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th.

Check Out Our Latest Analysis on PEPG

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. RTW Investments LP acquired a new position in shares of PepGen during the 4th quarter worth approximately $12,102,000. Janus Henderson Group PLC increased its holdings in shares of PepGen by 331.2% in the third quarter. Janus Henderson Group PLC now owns 2,336,516 shares of the company’s stock valued at $20,012,000 after purchasing an additional 1,794,641 shares during the last quarter. Suvretta Capital Management LLC raised its position in shares of PepGen by 9.2% in the third quarter. Suvretta Capital Management LLC now owns 1,660,932 shares of the company’s stock valued at $14,201,000 after purchasing an additional 140,000 shares during the period. Northern Trust Corp lifted its stake in shares of PepGen by 5.4% during the 4th quarter. Northern Trust Corp now owns 157,038 shares of the company’s stock worth $595,000 after buying an additional 7,984 shares during the last quarter. Finally, Millennium Management LLC boosted its holdings in shares of PepGen by 1,033.2% during the 4th quarter. Millennium Management LLC now owns 156,636 shares of the company’s stock worth $594,000 after buying an additional 142,814 shares during the period. 58.01% of the stock is currently owned by institutional investors and hedge funds.

PepGen Trading Down 10.2 %

PepGen stock traded down $0.27 during mid-day trading on Thursday, hitting $2.37. The stock had a trading volume of 584,136 shares, compared to its average volume of 774,048. PepGen has a 12 month low of $1.16 and a 12 month high of $19.30. The stock has a 50-day simple moving average of $2.28 and a two-hundred day simple moving average of $5.54. The stock has a market capitalization of $77.48 million, a PE ratio of -0.80 and a beta of 1.53.

PepGen (NASDAQ:PEPGGet Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported ($0.68) earnings per share for the quarter, beating the consensus estimate of ($0.81) by $0.13. Sell-side analysts expect that PepGen will post -2.73 earnings per share for the current fiscal year.

PepGen Company Profile

(Get Free Report)

PepGen Inc, a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients.

Further Reading

Receive News & Ratings for PepGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PepGen and related companies with MarketBeat.com's FREE daily email newsletter.